COST-EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH ASYMPTOMATIC TO MILD HEART FAILURE BASED ON THE EUROPEAN COHORT OF THE REVERSE STUDY FROM THE SPANISH HEALTH SYSTEM PERSPECTIVE

被引:0
|
作者
Quesada, A. [1 ]
Almenar, L. [2 ]
Diaz Molina, B. [3 ]
Crespo, C. [4 ]
Marti, B. [5 ]
Mealing, S. [6 ]
Linde, C. [7 ]
Daubert, C. [8 ]
机构
[1] Hosp Gen Valencia, Valencia, Spain
[2] Hosp Univ La Fe, Valencia, Spain
[3] Hosp Univ Cent Asturias, Oviedo, Spain
[4] Oblikue Consulting, Barcelona, Spain
[5] Medtron Iberia, Madrid, Spain
[6] Oxford Outcomes Ltd, Oxford, England
[7] Karolinska Univ Hosp, Solna, Sweden
[8] Ctr Hosp Univ, Rennes, France
关键词
D O I
10.1016/j.jval.2011.08.099
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A249 / A249
页数:1
相关论文
共 50 条
  • [31] (S)Ticker shock: The cost-effectiveness of cardiac resynchronization therapy with and without an implantable defibrillator in advanced symptomatic heart failure
    Kazi, Dhruv S.
    Hlatky, Mark A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A252 - A252
  • [32] Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective
    Savira, Feby
    Wang, Bing H.
    Kompa, Andrew R.
    Ademi, Zanfina
    Owen, Alice J.
    Zoungas, Sophia
    Tonkin, Andrew
    Liew, Danny
    Zomer, Ella
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (09) : 975 - 982
  • [33] Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective
    Savira, F.
    Wang, B. H.
    Kompa, A. R.
    Ademi, Z.
    Owen, A.
    Tonkin, A.
    Zoungas, S.
    Liew, D.
    Zomer, E.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1051 - 1051
  • [34] Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
    Mark Bounthavong
    Javed Butler
    Chantal M. Dolan
    Jeffrey D. Dunn
    Kathryn A. Fisher
    Nina Oestreicher
    Bertram Pitt
    Paul J. Hauptman
    David L. Veenstra
    PharmacoEconomics, 2019, 37 : 1071 - 1071
  • [35] Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care systemperspective
    Aidelsburger, P.
    Grabein, K.
    Klauss, V.
    Wasem, J.
    CLINICAL RESEARCH IN CARDIOLOGY, 2008, 97 (02) : 89 - 97
  • [36] Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care systemperspective
    Pamela Aidelsburger
    Kristin Grabein
    Volker Klauss
    Jürgen Wasem
    Clinical Research in Cardiology, 2008, 97 : 89 - 97
  • [37] Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials
    Lubitz, Steven A.
    Leong-Sit, Peter
    Fine, Nowell
    Kramer, Daniel B.
    Singh, Jagmeet
    Ellinor, Patrick T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (04) : 360 - 366
  • [38] FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE FROM THE PERSPECTIVE OF PRIVATE HEALTH CARE SYSTEM: COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT IN BRAZIL
    Campagnaro, M.
    Picoli, R. M.
    Castelano, N.
    Clemente, V
    Serna, Ramirez de Arellano A.
    VALUE IN HEALTH, 2023, 26 (12) : S111 - S111
  • [39] Cost-Effectiveness Analysis of Implantable Cardiac Devices in Patients With Systolic Heart Failure: A US Perspective Using Real World Data
    Lu, Xiaoxiao
    Paly, Victoria F.
    Shah, Dhvani
    Tsintzos, Stelios
    CIRCULATION, 2019, 140
  • [40] Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data
    Shah, Dhvani
    Lu, Xiaoxiao
    Paly, Victoria F.
    Tsintzos, Stelios, I
    May, Damian M.
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 690 - 697